CATALENT GERMANY SCHORNDORF GMBH TRADE DATA ANALYSIS
Access comprehensive trade data for Catalent Germany Schorndorf Gmbh with ease. Explore trade shipments, top suppliers & buyers, and values without the hassle.
Catalent Germany Schorndorf Gmbh – Overview
Eximpedia analyzes Catalent Germany Schorndorf Gmbh export and import records, including data from 0 buyers and 1 suppliers. We provide an intelligence report of Catalent Germany Schorndorf Gmbh that covers trade statistics, shipment values, quantities, exporters & importers and trade destinations
Catalent Germany Schorndorf Gmbh Buyers, Suppliers & Shipments
Catalent Germany Schorndorf Gmbh import markets
Explore the Catalent Germany Schorndorf Gmbh import market with monthly import values, major importers, HS Codes, key ports, top suppliers, and competitors
TOP IMPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 3006930000 | 5.84 | 7 | 31.82 |
| PHARMACEUTICAL GOODS SPECIFIED IN NOTE 4 TO THIS CHAPTER | |||
| 3004900000 | 5.63 | 9 | 40.91 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3002150000 | 1.80 | 5 | 22.73 |
| HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | |||
| 9025190090 | 0.00 | 1 | 4.55 |
| HYDROMETERS AND SIMILAR FLOATING INSTRUMENTS, THERMOMETERS, PYROMETERS, BAROMETERS, HYGROMETERS AND PSYCHROMETERS, RECORDING OR NOT, AND ANY COMBINATION OF THESE INSTRUMENTS | |||
TOP IMPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| GERMANY | 8.62 | 6 | 27.27 |
| SWITZERLAND | 2.60 | 4 | 18.18 |
| UNITED STATES | 1.12 | 7 | 31.82 |
| POLAND | 0.82 | 2 | 9.09 |
| GREAT BRITAIN | 0.10 | 2 | 9.09 |
TOP IMPORT PORTS
| PORT NAME | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| UA209230 | 12.26 | 21 | 95.45 |
| UA100380 | 1.01 | 1 | 4.55 |
TOP IMPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| LLC PAREXEL INTERNATIONAL RUS | 5.57 | 49 |
| AMGEN LLC | 8.91 | 108 |
| ENTERPRISE WITH | 11.79 | 916 |
| REPRESENTATIVE OFFICE OF JANSSEN PHARMACEUTICALS NV | 16.67 | 37 |
| LLC SANAKLIS | 37.34 | 119 |
TOP IMPORT SUPPLIERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| AMGEN EUROPE B V CLINICAL | 6.64 | 10 |
| F HOFFMANN LA ROCHE LIMITED | 10.93 | 2201 |
| CATALENT GERMANY SCHORNDORF GMBH | 11.68 | 398 |
| JANSSEN PHARMACEUTICA NV | 14.55 | 4338 |
| F HOFFMANN THE ROCK LIMITED | 26.07 | 24 |
If you are looking to establish relationship with Catalent Germany Schorndorf Gmbh Automation you can save time by getting access to the key decision makers and get a detailed report.
Catalent Germany Schorndorf Gmbh Import Shipments
Discover the Catalent Germany Schorndorf Gmbh with product description, import values, quantities, exporter name, country of origin and key destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 3006930000 | 1. PHARMACEUTICAL PRODUCTS: PLACEBOS AND KITS FOR BLIND (OR DOUBLE-BLIND) CLINICAL TRIALS USED EXCLUSIVELY IN INDEPENDENT CLINICAL TRIALS ACCORDING TO INCMGA PROTOCOL 0012-304. CONTAINS THE INVESTIGATIONAL MEDICINAL PRODUCT INCMGA00012 OR PLACEBO, OR BOTH, AND IS INTENDED FOR ANONYMOUS (BLIND) USE OF THE MEDICINAL PRODUCT. UNREGISTERED MEDICINAL PRODUCTS ARE INTENDED FOR CLINICAL TRIALS OF MEDICINAL PRODUCTS ON HUMANS. NOT FOR SALE. NOT OF ANIMAL ORIGIN. ""RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY TO EVALUATE CHEMOTHERAPY WITH PLATINUM-BASED DRUGS IN COMBINATION WITH OR WITHOUT INCMGA00012 AS FIRST-LINE THERAPY IN METASTATIC SQUAMOUS AND NON-SQUAMOUS NON-SMALL CELL LUNG CANCER"" - SOLUTION FOR INFUSION OF INCMGA00012, WITH A CONCENTRATION OF 25 MG/ML, OR PLACEBOCONTENTS: THE SET CONTAINS 1 SINGLE-USE BOTTLE OF 375 MG/15 ML OF THE DRUG INCMGA00012 OR PLACEBO - 18 PCS. SERIES NO.: 9150080-902 (FILL LOTS 036H21 AND 017D19) EXPIRY DATE: 04/30/2025" |  |
|
UNITED STATES | UKRAINE | 0 |
| 9025190090 | 1. ELECTRONIC TEMPERATURE SENSORS, SELF-CONTAINED THERMO-MONITORS, DISPOSABLE, FOR TEMPERATURE CONTROL DURING TRANSPORTATION AND STORAGE OF GOODS WITH SPECIAL TEMPERATURE REQUIREMENTS, FOR USE EXCLUSIVELY ACCORDING TO THE RESEARCH PROTOCOL MS100070_0176. WITH A BUILT-IN ""4 USB"" TYPE CONNECTOR FOR READING DATA TO A PC, PDF RECORDER. NOT FOR SALE.- TEMPERATURE SENSOR Q-TAG MODEL CLM 02-08-M5 T 2C-8C 60MIN - 50 PCS. SERIES NO.: BCK-01146 EXPIRATION DATE: MAY 31, 2026. NET WEIGHT: 0.08 X 50 PCS = 4 KG. COUNTRY OF ORIGIN: SWITZERLAND. MANUFACTURER: BERLINGER & CO. AG""" | |
|
SWITZERLAND | UKRAINE | 0 |
| 3002150000 | 1. UNREGISTERED MEDICINAL PRODUCTS FOR HUMANS. MONOCLONAL ANTIBODY (ARTIFICIALLY SYNTHESIZED ANALOGUE OF NATURAL SUBSTANCES) IS A RECOMBINANT MONOCLONAL ANTIBODY WHOSE PEPTIDE SEQUENCE IS IDENTICAL TO HUMAN LGG1. NOT OF ANIMAL ORIGIN. NOT FOR SALE. INTENDED FOR USE EXCLUSIVELY FOR CLINICAL RESEARCH ACCORDING TO THE PROTOCOL: INCMGA 0012-304 IN METASTATIC SQUAMOUS AND NON-SQUAMOUS LUNG CANCER. - SOLUTION FOR INFUSION OF THE DRUG INCMGA00012 WITH A CONCENTRATION OF 25 MG/ML, THE SET CONTAINS: 1 SINGLE-USE VIAL OF 375 MG/15 ML OF THE DRUG INCMGA00012 - 25 PCS. SERIES NO.: 9150080-022 (FILL LOTS 036H21) EXPIRY DATE: 31.08.2025. NET WEIGHT: 0.02 KG X 25 PCS = 0.5 KG. MANUFACTURER: CATALENT BIOLOGICS LIMITED, USA COUNTRY OF ORIGIN: USA | |
|
UNITED STATES | UKRAINE | 0 |
| 3004900000 | 1. UNREGISTERED MEDICINAL PRODUCTS FOR HUMANS. NOT OF ANIMAL ORIGIN. FOR USE ONLY WITHIN A CLINICAL TRIAL, STUDY PROTOCOL: MS200527-0086. AN OPEN-LABEL, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II STUDY OF M2951 WITH A PARALLEL GROUP OF ACTIVE CONTROL (TECFIDERA) IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS, SAFETY, TOLERABILITY, PHARMACOKINETICS AND BIOLOGICAL ACTIVITY. - OPEN-LABEL PATIENT TREATMENT SET , CONTAINING: 1 BLISTER WITH 48 TABLETS M2951 (ACTIVE SUBSTANCE MSC2364447C) 25 MG - 2000 PCS. SERIES NO.: CT3268/39 (FILL LOT 016698 ) EXPIRY DATE: 30.09.2027 NET WEIGHT: 0.207 X 2000 PCS = 414.0 KG MANUFACTURER: MERCK KGAA, GERMANY | |
|
GERMANY | UKRAINE | 0 |
| 3004900000 | 1. UNAUTHORIZED MEDICINE FOR HUMAN USE ONLY IN CLINICAL STUDY PROTOCOL: M14-465. MEDICINE CONTAINS: ADALIMUMAB, SOLUTION FOR INJECTION 0.8ML ABOUT THE FILLED SYRINGE IN THE DOSAGE OF 40MG/0 ,8ML, 2 SYRINGES IN A PACKAGE. TOTAL QUANTITY - 240 PACKAGES; PURPOSE - TREATMENT OF PATIENTS WITH MEDIUM OR SEVERE FORM OF RHEUMATOID ARTHRITIS. SERIES: 23-007719, EXPIRY DATE: 31.10.2026 MANUFACTURER: VETTER PHARMA-FERTIGUNG GMBH&CO.KG .TRADEMARK:ABBVIE INC.COUNTRY OF ORIGIN:DE | |
|
GERMANY | UKRAINE | 0 |
| 3006930000 | 1. KITS FOR BLIND (OR DOUBLE-BLIND) CLINICAL TRIALS ARE INTENDED EXCLUSIVELY FOR BLINDED MEDICAL TRIALS UNDER THE PROTOCOL MS200527_0080. CONTAINS EVOBRUTINIB COMPARED WITH TERIFLUNOMIDE AS AN INVESTIGATIONAL DRUG, OR A PLACEBO, OR BOTH AND ARE INTENDED FOR ANONYMOUS USE OF THE DRUG. UNREGISTERED DRUGS ARE INTENDED FOR CLINICAL DRUG TRIALS ON PEOPLE THE DRUGS DO NOT BELONG TO NARCOTICS, PSYCHOTROPIC SUBSTANCES AND PRECURSORS. NOT FOR SALE. NOT OF ANIMAL ORIGIN. ""MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, TO EVALUATE THE EFFICACY AND SAFETY OF EVOBRUTINIB VERSUS TERIFLUNOMIDE IN PARTICIPANTS WITH RELAPSING MULTIPLE SCLEROSIS"" - INVENTORY NUMBER: 379682 / 379683 - LABELED BLISTER MSC2364447C (EVOBRUTINIB) CONTAINING: 2 X (30X45MG TABLETS OR 30X PLACEBO 45MG) FILM-COATED TABLETS - 510 PCS. SERIES NO. 217413/61 (FILL LOTS: 016635/016683/016684) NET WEIGHT: 0.184 KG X 510 PCS. = 93.84 KG EXPIRY DATE: AUGUST 31, 2025 - INVENTORY NUMBER: 379684 / 379685 - LABELED BLISTER TERIFLUNOMIDE (AUBAGIO) CONTAINING: 1 X (30X14MG TABLETS OR 30X PLACEBO 14MG) TABLETS COVERED WITH A FILM COVER - 477 PCS. SERIES NO. 217413/82 ( FILL LOTS: 3AX4F / 016564) NET WEIGHT: 0.143 KG X 477 PCS. = 68.21 KG EXPIRY DATE: DECEMBER 31, 2024. MANUFACTURER: MERCK HEALTHCARE KGAA, GERMANY""" | |
|
GERMANY | UKRAINE | 0 |
| 3006930000 | 1. KITS FOR BLIND (OR DOUBLE-BLIND) CLINICAL TRIALS ARE INTENDED EXCLUSIVELY FOR BLINDED MEDICAL TRIALS UNDER THE PROTOCOL MS200527_0082. CONTAINS EVOBRUTINIB COMPARED WITH TERIFLUNOMIDE AS AN INVESTIGATIONAL DRUG, OR A PLACEBO, OR BOTH AND ARE INTENDED FOR ANONYMOUS USE OF THE DRUG. UNREGISTERED MEDICINAL PRODUCTS ARE INTENDED FOR CLINICAL DRUG TRIALS ON PEOPLE NOT FOR SALE. NOT OF ANIMAL ORIGIN. ""MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, EFFICACY AND SAFETY OF EVOBRUTINIB VERSUS TERIFLUNOMIDE IN PARTICIPANTS WITH RELAPSING MULTIPLE SCLEROSIS"" - INVENTORY NUMBER: 379678 / 379679 - MSC2364447C (EVOBRUTINIB) LABELED BLISTER CONTAINING 2 X (30 X 45MG TABLETS OR 30 X 45MG PLACEBO TABLETS) FILM-COATED TABLETS - 804 PCS. SERIES NO.: 217414/70 (FILL LOTS 016635, 016685, 016590) NET WEIGHT: 0.184 KG X 804 PCS. = 147.94 KG EXPIRY DATE: 10/31/2024. - INVENTORY NUMBER: 379680 / 379681 - LABELED BLISTER TERIFLUNOMIDE (AUBAGIO) CONTAINING: 1 X (30 X 14MG TABLETS OR 30 X 14MG PLACEBO TABLETS) FILM-COATED TABLETS - 804 PCS. BATCH NO.: 217414/80 (FILL LOTS 3AX4E, 016564 (KH20/0365)) NET WEIGHT: 0.143 KG X 804 = 114.97 KG EXPIRY DATE: 12/31/2024. MANUFACTURER: MERCK HEALTHCARE KGAA, GERMANY""" | |
|
GERMANY | UKRAINE | 0 |
| 3002150000 | 1. UNAUTHORIZED HUMAN MEDICINAL PRODUCTS FOR CLINICAL INVESTIGATION USE ONLY UNDER PROTOCOL: MS100070_0176 .OPEN, MULTICENTER FOLLOW-UP STUDY FOR COLLECTION OF LONG-TERM STUDY DATA SUMMARY OF SEVERAL CLINICAL STUDIES OF AVELUMAB (MSB0010718C). MONOCLONAL ANTIBODY (ARTIFICIALLY SYNTHESIZED ANALOG OF NATURAL SUBSTANCES) IS A RECOMBINATE MONOCLONAL ANTIBODIES WITH A PEPTIDE SEQUENCE IDENTICAL TO HUMAN LGG1. NOT OF ANIMAL ORIGIN. NOT FOR SALE. DRUGS DO NOT BELONG TO NARCOTICS, PSYCHOTROPIC SUBSTANCES AND PRECURSORS.- PATIENT KIT CONTAINING 15 VIALS AVELUMAB (MSB0010718C) 200MG/10ML VIAL, CONCENTRATE FOR PREPARATION OF SOLUTION FOR INTRAVENOUS INFUSION 20MG/ML IN 10ML VIALS - 27 SETS. SERIES #: CT3384 /20 (FILL LOTS PD1M005) EXPIRY DATE: AUGUST 11, 2026. NET WEIGHT: 0.665KG X 27 SETS = 17.95KG. MANUFACTURER: MERCK SERONO SA, CH | |
|
SWITZERLAND | UKRAINE | 0 |
| 3006930000 | 1. MEDICINAL PRODUCTS NOT REGISTERED, (NOT IN AEROSOL PACKAGING) FOR HUMANS INTENDED FOR CONDUCT OF BLIND (DOUBLE BLIND) CLINICAL TRIALS UNDER SOR102-101 PROTOCOL NOT FOR RETAIL SALE, NOT OF ANIMAL ORIGIN OVANI AS DOSAGE FORMS:- SOR102 135 MG OR PLACEBO, 40 CAPSULES IN BOTTLE #1 - 24 PCS.; PACKAGING SERIES: 34440001-01. EXPIRY DATE: 28/02/2025. MANUFACTURER: READING SCIENTIFIC SERVICES LIMITED. TRADEMARK: RSSL. COUNTRY OF MANUFACTURE GB." | |
|
GREAT BRITAIN | UKRAINE | 0 |
| 3004900000 | 1. UNAUTHORIZED HUMAN MEDICINE FOR USE ONLY IN A CLINICAL STUDY UNDER PROTOCOL: M14-465. MEDICINE CONTAINS: ADALIMUMAB, SOLUTION FOR INJECTION 0.8ML IN PRE FILLED SYRINGE IN DOSAGE OF 40MG/0 ,8ML, 2 SYRINGES IN A PACKAGE. TOTAL QUANTITY - 240 PACKAGES; PURPOSE - TREATMENT OF PATIENTS WITH MEDIUM OR SEVERE FORM OF RHEUMATOID ARTHRITIS. SERIES: 23-004553, EXPIRY DATE: 10/31/2025 MANUFACTURER: VETTER PHARMA-FERTIGUNG GMBH&CO.KG. TRADEMARK: ABBVIE INC. COUNTRY OF ORIGIN: DE | |
|
GERMANY | UKRAINE | 0 |
| 3004900000 | 1. UNREGISTERED MEDICINES FOR HUMAN USE. NOT OF ANIMAL ORIGIN. INTENDED FOR CLINICAL STUDY USE ONLY IN PROTOCOL: INCMGA 0012-304 IN METASTATIC SQUAMOUS AND NON-SQUAMOUS LUNG CANCER.- PEMETREXED 500MG, POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500MG/VIAL (25MG/ML) - 80 PCS. LOT NO.: CT3429/73 (FILL LOT P2206766) EXPIRY DATE: 28/04/2025. NET WEIGHT: 0.06KG * 80 PCS = 4.8KG. MANUFACTURER: ACCORD HEALTHCARE LIMITED, UK; COUNTRY OF ORIGIN: GREAT BRITAIN" | |
|
GREAT BRITAIN | UKRAINE | 0 |
| 3004900000 | 1. UNREGISTERED MEDICINES FOR HUMAN USE. NOT OF ANIMAL ORIGIN. INTENDED FOR CLINICAL STUDY USE ONLY: INCMGA 0012-304 IN METASTATIC SQUAMOUS AND NON-SQUAMOUS LUNG CANCER. - PACK OF 3 CAPSULES EMEND (APREPITANT) 1 CAPSULE 125MG, 2 CAPSULES 0 MG. (ANTIVOMETIC PREPARATION) - 60 PIECES. LOT NO.: CT3429/72 (FILL LOT X012469) EXPIRY DATE: 30.03.2025. NET WEIGHT: 0.055 KG * 60 PACK = 3.30 KG. MANUFACTURER: MERK SHARP & DOHME BV, NETHERLANDS; COUNTRY OF ORIGIN: THE NETHERLANDS" | |
|
NETHERLANDS | UKRAINE | 0 |
| 3002150000 | 1. UNAUTHORIZED HUMAN MEDICINAL PRODUCTS AWARDED FOR CLINICAL TRIAL USE ONLY UNDER PROTOCOL: MS100070_0176 .AN OPEN-LABEL, MULTICENTER FOLLOW-UP STUDY TO COLLECT LONG-TERM DATA ON PARTICIPANTS IN SEVERAL CLINICAL TRIALS OF AVELUMAB (MSB0010718C). MONOCLONAL ANTIBODY (ARTIFICIALLY SYNTHESIZED ANALOGUE OF NATURAL SUBSTANCES) IS A RECOMBINANT MONOCLONAL ANTIBODY WHOSE PEPTIDE SEQUENCE IS IDENTICAL TO HUMAN LGG1. NOT OF ANIMAL ORIGIN. NOT FOR SALE. THE DRUGS DO NOT BELONG TO NARCOTIC DRUGS, PSYCHOTROPIC SUBSTANCES AND PRECURSORS. - PATIENT SET CONTAINING 15 VIALS OF AVELUMAB (MSB0010718C) 200MG/10ML VIAL, CONCENTRATE FOR PREPARATION OF SOLUTION FOR INTRAVENOUS INFUSION 20MG/ML IN 10ML VIALS - 23 SETS. SERIES #: CT3384 /16 (FILL LOTS PD1K007/2) EXPIRY DATE: JULY 10, 2024. NET WEIGHT: 0.516 KG X 23 SETS = 11.87 KG. MANUFACTURER: MERCK SERONO SA, CH | |
|
SWITZERLAND | UKRAINE | 0 |
| 3002150000 | 1. UNREGISTERED MEDICINES FOR HUMAN USE. MONOCLONAL ANTIBODY (ARTIFICIALLY SYNTHESIZED ANALOGUE OF NATURAL SUBSTANCES) IS RECOMBINATE MONOCLONAL ANTIBODIES, THE PEPTIDE SEQUENCE OF WHICH IS IDENTICAL TO HUMAN LGG1. NOT OF ANIMAL ORIGIN. NOT FOR SALE. INTENDED FOR USE ONLY FOR CLINICAL RESEARCH UNDER PROTOCOL: INCMGA 0012-304 IN METASTATIC SQUAMOUS AND NON-SQUAMOUS LUNG CANCER. - SOLUTION FOR INFUSION OF THE DRUG INCMGA00012 WITH A CONCENTRATION OF 25MG/ML, THE SET CONTAINS: 1 DISPOSABLE VIAL OF 375MG/15ML OF THE PREPARATION INCMGA00012 - 20 PCS. SERIES #: 9150080-022 (FILL LOTS 036H21) EXPIRY DATE: 31.08.2025. NET WEIGHT: 0.02 KG X 20 PCS = 0.4 KG. MANUFACTURER: CATALENT BIOLOGICS LIMITED, USA COUNTRY OF ORIGIN: USA" | |
|
UNITED STATES | UKRAINE | 0 |
| 3006930000 | 1. KITS FOR BLIND (OR DOUBLE-BLIND) CLINICAL TRIALS ARE INTENDED EXCLUSIVELY FOR BLINDED MEDICAL TRIALS UNDER THE PROTOCOL MS200527_0082. CONTAINS EVOBRUTINIB COMPARED WITH TERIFLUNOMIDE AS AN INVESTIGATIONAL DRUG, OR A PLACEBO, OR BOTH AND ARE INTENDED FOR ANONYMOUS USE OF THE DRUG. UNREGISTERED MEDICINAL PRODUCTS ARE INTENDED FOR CLINICAL DRUG TRIALS ON PEOPLE NOT FOR SALE. NOT OF ANIMAL ORIGIN. ""MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, EFFICACY AND SAFETY EVALUATION OF EVOBRUTINIB VERSUS TERIFLUNOMIDE IN PARTICIPANTS WITH RELAPSING MULTIPLE SCLEROSIS"" - INVENTORY NUMBER: 379680 / 379681 - TERIFLUNOMIDE (AUBAGIO) LABELED BLISTER CONTAINING: 1 X (30 X 14MG TABLETS OR 30 X 14MG PLACEBO TABLETS) TABLETS COVERED WITH A FILM COVER - 380 PCS. SERIES NO.: 217414/80 (FILL LOTS 3AX4E & KH20/0365 & 016564 ) NET WEIGHT: 0.143 KG X 380 = 54.34 KG EXPIRY DATE: 31.12.2025. MANUFACTURER: MERCK HEALTHCARE KGAA, GERMANY" | |
|
SWITZERLAND | UKRAINE | 0 |
| 3006930000 | 1. KITS FOR BLIND (OR DOUBLE-BLIND) CLINICAL TRIALS ARE INTENDED EXCLUSIVELY FOR BLINDED MEDICAL TRIALS UNDER THE PROTOCOL MS200527_0080. CONTAINS EVOBRUTINIB COMPARED WITH TERIFLUNOMIDE AS AN INVESTIGATIONAL DRUG, OR A PLACEBO, OR BOTH AND ARE INTENDED FOR ANONYMOUS USE OF THE DRUG. UNREGISTERED DRUGS ARE INTENDED FOR CLINICAL DRUG TRIALS ON PEOPLE THE DRUGS DO NOT BELONG TO NARCOTICS, PSYCHOTROPIC SUBSTANCES AND PRECURSORS. NOT FOR SALE. NOT OF ANIMAL ORIGIN. ""MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, EFFICACY AND SAFETY OF EVOBRUTINIB VERSUS TERIFLUNOMIDE IN PARTICIPANTS WITH RELAPSING MULTIPLE SCLEROSIS"" - MSC2364447C (EVOBRUTINIB) LABELED BLISTER CONTAINING 2 X (30 X 45MG TABLETS OR 30 X PLACEBO) TABLETS COVERED WITH A FILM SHELL - 573 PCS. SERIES NO. 217413/61 (MANUFACTURER'S SERIES 016635/G0173L & 016685/G01FM) EXPIRY DATE: AUGUST 31, 2024 - LABELED BLISTER TERIFLUNOMIDE (AUBAGI" | |
|
GERMANY | UKRAINE | 0 |
| 3006930000 | 1. MEDICINAL PRODUCTS (NOT IN AEROSOLS) FOR HUMAN USE FOR BLIND (DOUBLE BLIND) CLINICAL TRIALS ACCORDING TO PROTOCOL VE202-002 NOT FOR RETAIL SALE, NOT OF ANIMAL ORIGIN, PACKAGED BY DOSE AVAILABLE FORMS:- VANCOMYCIN 125MG OR PLACEBO, 24 CAPSULES IN BOTTLE #1 - 66 PCS.; PACKAGING SERIES: 5359091. EXPIRY DATE - 04/30/2024. MANUFACTURER: CATALENT CTS, LLC. TRADEMARK - CATALENT. COUNTRY OF MANUFACTURE US | |
|
UNITED STATES | UKRAINE | 0 |
| 3004900000 | 1. UNREGISTERED MEDICINAL PRODUCTS FOR HUMANS, INTENDED FOR USE EXCLUSIVELY FOR CLINICAL RESEARCH UNDER THE PROTOCOL: PCYC-1143-CA. THE DRUGS DO NOT BELONG TO NARCOTICS, PSYCHOTROPIC SUBSTANCES AND PRECURSORS. NOT FOR SALE. PHASE 3 STUDY EVALUATING THE USE OF IBRUTINIB IN COMBINATION WITH VENETOCLAX IN PATIENTS WITH MANTLE CELL LYMPHOMA (MCL).-373478 IBRUTINIB (IBRUTINIB) CAPSULE 140 MG, 120 CAPSULES IN A BOTTLE - 28 BOTTLES SERIES NO.: 5094783B1 EXPIRY DATE: JUNE 30, 2025.-259926 / IBRUTINIB (IBRUTINIB ) TABLETS 560 MG, 28 TABLETS IN A BLISTER - 68 PCS. SERIES NO.: 4744832A1 EXPIRY DATE: SEPTEMBER 30, 2024. MANUFACTURER: CATALENT CTS, LLC. USA""" | |
|
UNITED STATES | UKRAINE | 0 |
| 3004900000 | 1. UNREGISTERED MEDICINAL PRODUCTS FOR HUMANS. NOT OF ANIMAL ORIGIN. WHICH ARE INTENDED FOR USE EXCLUSIVELY FOR CLINICAL RESEARCH ACCORDING TO THE PROTOCOL: INCMGA 0012-304 IN METASTATIC SQUAMOUS CELL AND NON-SQUAMOUS CELL LUNG CANCER. - PEMETREXED 500 MG, POWDER FOR CONCENTRATE FOR PREPARATION OF SOLUTION FOR INFUSION 500 MG/VIAL (25 MG/ML) - 61 PCS. BATCH NO.: CT3429/71 - P2300596 EXPIRY DATE: 31/05/2025 NET WEIGHT: 0.04KG * 61 PCS = 2.44KG MANUFACTURER: ACCORD HEALTHCARE POLSKA SP.Z OO, PABIANICE, POLAND COUNTRY OF ORIGIN: POLAND | |
|
POLAND | UKRAINE | 0 |
| 3004900000 | 1. UNREGISTERED MEDICINAL PRODUCTS FOR HUMANS, INTENDED FOR USE EXCLUSIVELY IN CLINICAL RESEARCH ACCORDING TO THE PROTOCOL: M14-465. MEDICINAL PRODUCT IN THE COMPOSITION: - UPADACITINIB (ABT-494), IN A DOSAGE OF 15 MG, CONTAINING 100 TABLETS OF OBLONG, BICONVEX SHAPE, YELLOW COLOR IN THE BOTTLE. TOTAL QUANTITY - 200 VIALS; PURPOSE - TREATMENT OF PATIENTS WITH MODERATE OR SEVERE RHEUMATOID ARTHRITIS. SERIES: 23-004547, EXPIRATION DATE: 10/31/2027 MANUFACTURER: ABBVIE INCTRADEMARK: ABBVIE COUNTRY OF ORIGIN: US""" | |
|
UNITED STATES | UKRAINE | 0 |
Get Started with Eximpedia
Start 5 Days Free Trial
No Pay, No Delay - 5 days Your Way!
Book a Free Demo
Learn How our platform works in just 20 minutes!
Download Free Sample Report
Free Import-Export Sample data-One Click Away!
Why should you choose Eximpedia?
Broad Range of Country Datasets
Our dedicated team of experts delivers current and flexible data from key global locations, enabling you to make essential decisions with vital information and insights.
Easy to understand deep analysis
We use bespoke layered visualizations for diving deep into our country and logistics data to provide your team with graphical assistance and essential data analysis and reporting.
Most Accurate Information
All of our datasets are quality-controlled by layers of inspection before it ever reach your platform. This helps us maintain the high reliability our clients have come to trust.
Competitive Supplier Engagement Watch
Keep an eye out for any collaboration between your suppliers and your rivals, as this may impact their ability to satisfy your requirements.
Right away on-screen support
With instant remote on-screen assistance, chat support, and user training, our customer success team is available to you around the clock.
Access Database Across 130+ Countries
Explore competitors' shipment histories, statistical and analytical reports, and country-specific information from more than 130 nations.
Catalent Germany Schorndorf Gmbh frequently asked questions
You can explore detailed shipment records of Catalent Germany Schorndorf Gmbh through Eximpedia’s real-time trade insights platform, which provides access to shipment dates, quantities, ports, and product details.
Yes, Eximpedia offers a directory of buyers with similar trade patterns to Catalent Germany Schorndorf Gmbh. Use advanced filters to identify competitors or partners in the same industry.
With our data-driven platform, you can access a curated list of suppliers with comparable product categories and shipment volumes to Catalent Germany Schorndorf Gmbh, helping you expand your sourcing network.
Eximpedia’s trade data highlights Catalent Germany Schorndorf Gmbh’s major exports, along with their trade destinations and origins.
We provide detailed analytics, including trade volumes, market trends, port usage, and competitor insights, to help businesses understand Catalent Germany Schorndorf Gmbh’s trade activities.
Traders can collaborate with Catalent Germany Schorndorf Gmbh by contacting them through their official channels or visiting their headquarters for detailed trade discussions.